Clinical Trial Update: A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial assessing albuterol with hydrofluoroalkane in adolescents and adults with persistent asthma; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol (albuterol)
• Hydrofluoroalkane (hydrofluoroalkane)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-08